CVS HEALTH CORP (CVS) Stock Institutional Trading Activity
CVS HEALTH CORP (CVS) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q4 2025), investors with some of the largest reported share count changes include Hancock Classic Value, Ariel Appreciation Fund, Olstein Capital Management, Cullen Value Fund, and Tweedy, Browne Co All Funds (US). Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.
Explore more:
- CVS HEALTH CORP (CVS) stock institutional ownership
- CVS HEALTH CORP (CVS) stock insider trading activity
- Stock rankings
| Portfolio quarter | Name | Type | Quantity | Remaining | Reported stock balance |
|---|---|---|---|---|---|
| Q3 2020 | Matrix Private Capital Group | Buy | 796 | 18,413 | $1,075 |
| Q3 2020 | Hillman Value Fund | Buy | 10,158 | 81,096 | $4,736 |
| Q3 2020 | Muhlenkamp & Co | Buy | 911 | 107,459 | $6,276 |
| Q3 2020 | Scion Asset Management | Buy | 150,000 | 150,000 | $8,760 |
| Q3 2020 | Matrix Advisors Value Fund | Buy | 6,057 | 332,061 | $19,392 |
| Q3 2020 | Renaissance Technologies LLC | Buy | 739,739 | 1,818,923 | $106,225 |
| Q3 2020 | Vulcan Value Partners | Sell | -1,332,165 | 3,051,845 | $178,228 |
| Q3 2020 | Hancock Classic Value | Buy | 43,418 | 1,158,394 | $67,650 |
| Q2 2020 | Torray Fund | Sell | -1,869 | 24,727 | $1,607 |
| Q2 2020 | Dodge & Cox Stock Fund | Sell | -4,862,218 | 16,001,738 | $1,039,633 |
| Q2 2020 | Sequoia Financial Advisors | Sell | -5,299 | 0 | $470 |
| Q2 2020 | Matrix Private Capital Group | Buy | 3,582 | 17,617 | $1,145 |
| Q2 2020 | Hillman Value Fund | Buy | 18 | 70,938 | $4,609 |
| Q2 2020 | Muhlenkamp & Co | Buy | 34 | 106,548 | $6,922 |
| Q2 2020 | Matrix Advisors Value Fund | Sell | -2,861 | 326,004 | $21,180 |
| Q2 2020 | Renaissance Technologies LLC | Sell | -192,069 | 1,079,184 | $70,115 |
| Q2 2020 | Vulcan Value Partners | Sell | -924,705 | 4,384,010 | $284,829 |
| Q1 2020 | Olstein Capital Management | Buy | 19,500 | 144,000 | $8,544 |
| Q1 2020 | Torray Fund | Buy | 26,596 | 26,596 | $1,578 |
| Q1 2020 | Dodge & Cox Stock Fund | Buy | 368,385 | 20,863,956 | $1,237,859 |
| Q1 2020 | Sequoia Financial Advisors | Buy | 566 | 5,299 | $314 |
| Q1 2020 | Matrix Private Capital Group | Buy | 14,035 | 14,035 | $833 |
| Q1 2020 | Hillman Value Fund | Sell | -286 | 70,920 | $4,208 |
| Q1 2020 | Matrix Advisors Value Fund | Buy | 28,778 | 328,865 | $19,512 |
| Q1 2020 | Renaissance Technologies LLC | Buy | 1,258,200 | 1,271,253 | $75,423 |
| Q1 2020 | Vulcan Value Partners | Sell | -1,373,177 | 5,308,715 | $314,966 |
| Q1 2020 | Hancock Classic Value | Buy | 163,186 | 1,114,976 | $66,152 |
| Q4 2019 | Olstein Capital Management | Sell | -61,800 | 124,500 | $9,249 |
| Q4 2019 | Mairs & Power Growth Fund | Buy | 130 | 2,873 | $213 |
| Q4 2019 | Vulcan Value Partners | Sell | -2,073,020 | 6,681,892 | $496,398 |
Frequently asked questions about CVS activity
Which institutional owners are buying CVS?
Institutional owners buying CVS include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in CVS activity?
"Buy" means an investor increased their reported position in CVS compared to the prior reporting period. This reflects growing exposure to CVS HEALTH CORP (CVS) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in CVS increasing?
Institutional interest in CVS can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.